Inventor · disambiguated record
Felix Unverdorben
Also filed as: UNVERDORBEN FELIX
13 granted patents·18 pending applications·43 citations·filing 2012–2025
88Inventor score
Top patents by PatentIndex Score
31 records- 0196US10618956B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Apr 14, 2020·13 cites·16 claims
- 0295US11104894B2Method for preparing electrocompetent yeast cells, and method for using said cellsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Aug 31, 2021·3 cites·18 claims
- 0394US10889645B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 12, 2021·3 cites·20 claims
- 0493US10428120B2Serum half-life extension using IgBDUNIV STUTTGART·Filed 2017·Granted Oct 1, 2019·19 cites·6 claims
- 0590US11840577B2Antigen binding proteins specifically binding MAGE-AIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Dec 12, 2023·2 cites·9 claims
- 0689US10683495B2Method for preparing electrocompetent yeast cells, and method for using said cellsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jun 16, 2020·3 cites·19 claims
- 0786US2025361300A1Improved dual specificity polypeptide moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2025·Application pending·0 cites
- 0884US2023348598A1Improved dual specificity polypeptide moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 0984US2024228611A1Novel engineered t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 1083US12269881B2Antigen binding proteins specifically binding MAGE-AIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Granted Apr 8, 2025·0 cites·8 claims
- 1179US2024052054A1Antigen binding proteins specifically binding mage-aIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 1278US2022185888A1Dual specificity polypeptide moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 1378US2022195044A1Dual specificity polypeptide moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 1477US11859009B2Antigen binding proteins specifically binding PRAMEIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 2, 2024·0 cites·30 claims
- 1577US2025051445A1Bma031 antigen binding polypeptidesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 1677US2024092933A1Antigen binding proteins specifically binding prameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 1777US2025122302A1Antigen binding proteins specifically binding ct45IMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 1875US11932689B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Mar 19, 2024·0 cites·20 claims
- 1975US2023357428A1Antigen binding proteins specifically binding prameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 2073US12209137B2Antigen binding proteins specifically binding CT45IMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 28, 2025·0 cites·64 claims
- 2170US12162940B2BMA031 antigen binding polypeptidesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Dec 10, 2024·0 cites·15 claims
- 2270US2025215084A1Antigen binding proteins specifically binding mage-aIMMATICS BIOTECHNOLOGIES GMBH·Filed 2025·Application pending·0 cites
- 2369US2021355478A1Method for preparing electrocompetent yeast cells, and method for using said cellsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Application pending·0 cites
- 2468US2023203200A1Recruiting agent further binding an mhc moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 2567US11905328B2Dual specificity polypeptide moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Feb 20, 2024·0 cites·19 claims
- 2666US2025034227A1Antigen binding proteins against mageb2IMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2761US2025354995A1Mammalian display platform for multispecific antigen binding proteinsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 2858US2021032370A1Recruiting agent further binding an mhc moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Application pending·0 cites
- 2952US12480958B2Method for the characterization of peptide:MHC binding polypeptidesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Nov 25, 2025·0 cites·22 claims
- 3048US2023132241A1Antigen binding proteins specifically binding prameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Application pending·0 cites
- 3147US2014220017A1Serum half-life extension using igbdUNIV STUTTGART·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Felix Unverdorben files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →